Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC TL13-112 | 2229037-19-6 | MFCD12922943 | >98.0% | 1002.6 | C49H60ClN9O10S | 10MG
SDP

Supplier:  Medchemexpress LLC HY12391910MG

Encompass_Preferred

TL13-112 is a PROTAC research compound that targets anaplastic lymphoma kinase (ALK) for proteasomal degradation while inhibiting its kinase activity. It is a bifunctional molecule formed by conjugation of an ALK inhibitor with a cereblon-binding ligand and is used in cellular assays to study target degradation and downstream signaling.

  • Potent ALK inhibition (IC50 = 0.14 nM).
  • Induces degradation of Aurora A, FER, PTK2, and RPS6KA1 in cell assays.
  • Bifunctional PROTAC conjugate of ceritinib and a cereblon-binding pomalidomide ligand.
  • Chemical formula C49H60ClN9O10S; molecular weight ~1002.6 g/mol.
  • Reported analytical purity ≥98% (HPLC).
  • Intended for research use only; not for human or diagnostic applications.

Catalog No. 50-002-38298


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.